ClinConnect ClinConnect Logo
Search / Trial NCT00276328

Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults

Launched by IPSEN · Jan 12, 2006

Trial Information

Current as of May 19, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Acute diarrhoea episode defined as at least 3 watery stools per day for 48 hours or less
  • Patient with, usually, normal bowel habits, i.e. at least 3 stools per week and no more than 3 stools per day
  • Exclusion Criteria:
  • Gross blood, pus in the stools
  • Fever \>39ºC
  • Other episode of acute watery diarrhoea within the last 30 days
  • History of chronic diarrhoea or motor diarrhoea

About Ipsen

Ipsen is a global biopharmaceutical group dedicated to innovation and specialty care, focusing on the discovery, development, and commercialization of transformative medicines for patients with serious diseases. With a strong emphasis on oncology, neuroscience, and rare diseases, Ipsen leverages cutting-edge research and advanced technologies to deliver high-quality therapies that address unmet medical needs. Committed to scientific excellence and ethical practices, Ipsen collaborates with healthcare professionals and stakeholders to drive patient-centered solutions and improve health outcomes worldwide.

Locations

Casablanca, , Morocco

Casablanca, , Morocco

Casablanca, , Morocco

Casablanca, , Morocco

Casablanca, , Morocco

Casablanca, , Morocco

Rabat, , Morocco

Ben Arous, , Tunisia

La Marsa, , Tunisia

Menzel Bourguiba, , Tunisia

Monastir, , Tunisia

Nabeul, , Tunisia

Sfax, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Sousse, , Tunisia

Tunis, , Tunisia

Tunis, , Tunisia

Tunis, , Tunisia

Tunis, , Tunisia

Tunis, , Tunisia

Tunis, , Tunisia

Tunis, , Tunisia

Patients applied

0 patients applied

Trial Officials

Ipsen Medical Director

Study Director

Ipsen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials